be_ixf;ym_202105 d_18; ct_50

Select Page

Nick Tate

Nick TateNick Tate Senior Editorial Manager for Bold Profits Daily, Profits Unlimited and Paul Mampilly’s other premium trading publications.

Nick Tate is the senior editorial manager for Bold Profits Daily, Profits Unlimited and Paul Mampilly’s other premium trading publications.

As a best-selling author, seasoned journalist and TV commentator specializing in health care, finance and biotech, Nick is all about big ideas and innovations — always keeping his followers informed on the next big thing.

His work has appeared in The Miami Herald, The Atlanta Journal-Constitution, South Florida Business Journal, Newsmax Magazine, South Florida Sun Sentinel, Boston Herald, and on Newsmax TV and the Al Jazeera network.

His top-selling book, the ObamaCare Survival Guide, was on the Publishers Weekly and The New York Times best-sellers lists for 22 weeks — reaching No. 1 on The Times list for paperback advice books.

Tate also co-authored DaVinci’s Baby Boomer Survival Guide: Live, Prosper, and Thrive in Your Retirement. And he published two other books — the Encyclopedia of Natural Healing and The Sick Building Syndrome — following a year-long journalism fellowship at the Harvard School of Public Health.

Tate’s three-decades-long commitment to keeping the public well-informed is why Banyan Hill Publishing recruited him in 2018 to join Paul Mampilly’s team. You can now read Nick’s weekly analysis in Bold Profits Daily as he guides over 130,000 readers on the best ways to grow their wealth.

Nick Tate's Articles

AI + Precision Medicine = 1-2 Punch for America 2.0 Profits - Artificial intelligence and precision medicine are teaming up for a one-two punch that is reshaping America 2.0 health care — offering HUGE investment potential.
Get the Next Biotech Takeover Trade Today - America 2.0 biotech companies are reshaping our health care system. Here’s how to buy in before new mega trend medical marvels take the sector to new highs.
Buy Into Precision Medicine’s “Digital New Deal” Boost - The Digital New Deal contains billions to fund tech innovations in precision medicine. Here’s the top way to buy in before it skyrockets.
1 ETF to Buy Before Next 547% Gain in Genetics Testing - When the price for an in-demand tech product drops this much it’s the trigger for phenomenal gains.
First 3D-Printed Burger: No. 1 Way to Profit - It's the world’s first 3D-printed burger — pushing the technology into the mainstream and helping boost early investors’ profits.
3D-Printed Hearts = Your Path to 5X Profits - Make sure you’re in front of this new 3D printing breakthrough before the next 5X move.
2 Best ETFs for Precision Medicine’s “Breakout” Year - 2021 will be a breakout year for precision medicine. Here are two massive precision medicine ETFs you can buy today to get ready for the big gains ahead.
1 Sell Before $3.6 Trillion Precision Medicine Disruption - Here’s one old-world medicine sell and one precision medicine buy for your 2021 portfolio … before our nation’s $3.6 trillion health care disruption.
2021 Precision Medicine Plays for $1.5 Trillion Disruption - “Smart” pills are on track to disrupt the $1.5 trillion global drug market. Here’s how to leverage the America 2.0 precision medicine mega trend for mega profits.
Precision Medicine Alert: 2 Plays for 175% Growth - Investing in one precision medicine treatment (or the HUGE market) can lead you to the next medical fortune — like the early investors of the human genome, penicillin or any vaccine.

Newsletter Sign Up

Sponsored

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“I found Profits Unlimited in Summer 2016. Starting with about $20,000, I began following your recommendations and did my own thing as well. Four years later, I am happy to report my portfolio is now in the six figures."

- Andrew

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

"You told me to ignore the noise on Wall Street. And thanks to you, I started towards the end of 2016 with $200,000 in my account and I recently put in an extra $100,000. [As of February 2019] My account is worth $500,788! I would’ve missed out if I followed conventional wisdom."

- Helen C.